Retrieve available abstracts of 86 articles: HTML format
Single Articles
August 2025
PIRINI F, Calzari L, Tedaldi G, Tebaldi M, et al Comprehensive genetic and epigenetic characterization of Lynch-like syndrome
patients.
Int J Cancer. 2025;157:788-799. PubMedAbstract available
LARSEN PT, Jorgensen SF, Rasmussen M, Andersen B, et al Screening outcomes at second FIT screening in individuals with a first time
negative FIT-result or low-risk adenomas: Results from a nationwide FIT screening
program.
Int J Cancer. 2025;157:698-708. PubMedAbstract available
July 2025
TRIPATHI C, Tovar Perez JE, Kapoor S, Muhsin A, et al Antitumor efficacy of intermittent low-dose erlotinib plus sulindac via MHC
upregulation and remodeling of the immune cell niche.
Int J Cancer. 2025;157:355-370. PubMedAbstract available
LINSSEN JDG, Schafrat PJM, de Back TR, van Erning FN, et al Predisposing conditions in patients with small intestinal adenocarcinomas in the
Netherlands: A 20-year nationwide cohort study.
Int J Cancer. 2025;157:218-231. PubMedAbstract available
WIND KL, Steffensen JH, Jakobsen AV, Kronborg C, et al Prognostic significance of pre-treatment immune-inflammation biomarkers in anal
cancer: A study combining real-world data and a meta-analysis.
Int J Cancer. 2025;157:193-200. PubMedAbstract available
MOLLER L, Szentkiralyi A, Eisfeld C, Wellmann I, et al Incidence trends and relative survival of colorectal neuroendocrine neoplasms: A
population-based study using German cancer registry data.
Int J Cancer. 2025;157:116-125. PubMedAbstract available
June 2025
CHAPLIN A, Rodriguez RM, Barcelo-Nicolau M, Perez-Romero K, et al Plasma fatty acids depletion: A metabolic signature related to colon cancer.
Int J Cancer. 2025 Jun 23. doi: 10.1002/ijc.70015. PubMedAbstract available
SERGEEV D, Heisser T, Hoffmeister M, Brenner H, et al Potential for enhancing efficacy of screening colonoscopy by lowering starting
ages and extending screening intervals: A modelling study for Germany.
Int J Cancer. 2025;156:2303-2310. PubMedAbstract available
PASSEN CV, Krug J, Weiss L, Abdou MM, et al Integrin beta6 expression in colorectal cancer cells promotes liver metastasis
through enhanced adhesion to endothelial fibronectin.
Int J Cancer. 2025 Jun 9. doi: 10.1002/ijc.35504. PubMedAbstract available
KORSGAARD U, Kristensen MP, Garcia-Rodriguez JL, Kjaer-Frifeldt S, et al The prognostic potential of RNA in stage II colon cancer: Insights from a
screened multicenter population-based cohort study.
Int J Cancer. 2025 Jun 6. doi: 10.1002/ijc.35507. PubMedAbstract available
May 2025
VAN ZUTPHEN M, Verkaar AJCF, van Duijnhoven FJB, Voortman T, et al Early-life anthropometry and colorectal cancer risk in adulthood: Global Cancer
Update Programme (CUP Global) systematic literature review and meta-analysis of
prospective studies.
Int J Cancer. 2025 May 28. doi: 10.1002/ijc.35461. PubMedAbstract available
STERPETTI G, Sterpetti AV Increased mortality from colorectal cancer in younger individuals: The preventive
role of aspirin and statins.
Int J Cancer. 2025 May 27. doi: 10.1002/ijc.35495. PubMed
April 2025
HOANG T, Choi MK, Oh JH, Kim J, et al Utility of circulating tumor DNA to detect minimal residual disease in colorectal
cancer: A systematic review and network meta-analysis.
Int J Cancer. 2025 Apr 28. doi: 10.1002/ijc.35442. PubMedAbstract available
ZHOU Y, Fu M, Guan X, Wang C, et al Targeted plasma lipidomic profiles associated with colorectal cancer risk and
effect modifications by common risk factors and particulate matter exposure.
Int J Cancer. 2025 Apr 21. doi: 10.1002/ijc.35449. PubMedAbstract available
BLANKS RG, Alison RJ, Reeves GK Invitation for FOBt screening and colorectal cancer mortality: A prospective
analysis in the Million Women Study cohort.
Int J Cancer. 2025 Apr 11. doi: 10.1002/ijc.35437. PubMedAbstract available
GE X, Feng Y, Tan S, Mao W, et al Gestational colorectal cancer: Mechanisms, treatments, and prognosis.
Int J Cancer. 2025 Apr 3. doi: 10.1002/ijc.35425. PubMedAbstract available
March 2025
JOHANNSEN IR, Boysen AK, Mortensen FV, Kirkegard J, et al Temporal trends in incidence and mortality of colorectal cancer in Denmark from
2007 to 2022.
Int J Cancer. 2025 Mar 14. doi: 10.1002/ijc.35400. PubMedAbstract available
VAN NASSAU SCMW, Zwart K, van der Baan FH, Vink GR, et al Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic
colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohort.
Int J Cancer. 2025 Mar 13. doi: 10.1002/ijc.35410. PubMedAbstract available
DROSDOWSKY A, Lamb KE, Te Marvelde L, Gibbs P, et al Factors associated with diagnostic and treatment intervals in colorectal cancer:
A linked data study.
Int J Cancer. 2025 Mar 13. doi: 10.1002/ijc.35414. PubMedAbstract available
KATSARA MA, van den Berg D, Spaander MCW, van Vuuren AJ, et al The impact of extended invitation intervals on stage distribution of
screen-detected and interval cancer within the Dutch colorectal cancer screening
program.
Int J Cancer. 2025 Mar 13. doi: 10.1002/ijc.35371. PubMedAbstract available
February 2025
ZHANG Y, Song K, Zhou Y, Chen Y, et al Accuracy and long-term effectiveness of established screening modalities and
strategies in colorectal cancer screening: An umbrella review.
Int J Cancer. 2025 Feb 25. doi: 10.1002/ijc.35381. PubMedAbstract available
GALANOS LJK, Rijken A, Elferink MAG, Kok NFM, et al Influence of a nationwide colorectal cancer screening program on the incidence of
synchronous colorectal peritoneal metastases.
Int J Cancer. 2025 Feb 17. doi: 10.1002/ijc.35356. PubMedAbstract available
PEREMIQUEL-TRILLAS P, Martinez JM, Paytubi S, Frias-Gomez J, et al Acceptability and somatic mutations in cervicovaginal self-sampling for early
endometrial cancer detection in women with Lynch syndrome.
Int J Cancer. 2025 Feb 14. doi: 10.1002/ijc.35368. PubMedAbstract available
AL NAHAS A, Yammine Ghantous S, Morales Berstein F, Cakmak EK, et al Associations between degree of food processing and colorectal cancer risk in a
large-scale European cohort.
Int J Cancer. 2025 Feb 8. doi: 10.1002/ijc.35361. PubMedAbstract available
JIN F, Poynten IM, Hillman RJ, Law C, et al Does use of anal cytology as a triage test improve the performance of high-risk
human papillomavirus screening in gay and bisexual men for anal cancer
prevention?
Int J Cancer. 2025;156:575-586. PubMedAbstract available
January 2025
BYRD DA, Damerell V, Gomez Morales MF, Hogue SR, et al The gut microbiome is associated with disease-free survival in stage I-III
colorectal cancer patients.
Int J Cancer. 2025 Jan 31. doi: 10.1002/ijc.35342. PubMedAbstract available
AKKUS E, Karaoglan BB, Kayaalp M, Turmus U, et al Stage-specific characterization of "early-onset colorectal cancer": Localized and
synchronous metastatic disease.
Int J Cancer. 2025 Jan 30. doi: 10.1002/ijc.35336. PubMedAbstract available
HU X, Xie S, Yang Z, Zhao X, et al Aggressive characteristics of tumor deposits in colorectal cancer highlight the
need for staging refinement in patients with 0-3 metastatic lymph nodes.
Int J Cancer. 2025 Jan 20. doi: 10.1002/ijc.35306. PubMedAbstract available
OGUZ ERDOGAN AS, Simmer F, Nagtegaal ID Tumor deposits should not be placed in the M category of TNM: A comparative
survival analysis using SEER data.
Int J Cancer. 2025;156:274-279. PubMedAbstract available
DYER CEF, Jin F, Hillman RJ, Nyitray AG, et al Self-collected versus clinician-collected anal swabs for anal cancer screening: A
systematic review and meta-analysis.
Int J Cancer. 2025;156:79-90. PubMedAbstract available
December 2024
ADAMS J, Stebbing J Effects of MCL-1 expression in colorectal cancer.
Int J Cancer. 2024 Dec 30. doi: 10.1002/ijc.35308. PubMed
MITTAL P, Battaglin F, Baca Y, Xiu J, et al Comprehensive characterization of MCL-1 in patients with colorectal cancer:
Expression, molecular profiles, and outcomes.
Int J Cancer. 2024 Dec 30. doi: 10.1002/ijc.35304. PubMedAbstract available
VAN STIGT BJ, Lansdorp-Vogelaar I, Spaander MCW, van Vuuren AJ, et al Interval cancer risk after the upper age limit of screening has been reached:
Informing risk stratification in FIT-based colorectal cancer screening.
Int J Cancer. 2024 Dec 19. doi: 10.1002/ijc.35294. PubMedAbstract available
HUNG FH, Peng HP, Hung CF, Hsieh LL, et al Performance evaluation of predictive models for detecting MMR gene mutations
associated with Lynch syndrome in cancer patients in a Chinese cohort in Taiwan.
Int J Cancer. 2024;155:2201-2210. PubMedAbstract available
SONG Y, Ren S, Wu S, Liu W, et al Glucocorticoid promotes metastasis of colorectal cancer via co-regulation of
glucocorticoid receptor and TET2.
Int J Cancer. 2024 Dec 11. doi: 10.1002/ijc.35285. PubMedAbstract available
FORSTI A, Ambrozkiewicz F, Marciniak M, Lubinski J, et al Search for germline gene variants in colorectal cancer families presenting with
multiple primary colorectal cancers.
Int J Cancer. 2024 Dec 10. doi: 10.1002/ijc.35283. PubMedAbstract available
CAI R, Ke L, Zhao Y, Zhao J, et al NMR-based metabolomics combined with metabolic pathway analysis reveals metabolic
heterogeneity of colorectal cancer tissue at different anatomical locations and
stages.
Int J Cancer. 2024 Dec 4. doi: 10.1002/ijc.35273. PubMedAbstract available
November 2024
SHAHRIVAR M, Dietrich CE, Glimelius B, Saraste D, et al Type II diabetes and metformin use does not affect colorectal cancer prognosis.
Int J Cancer. 2024 Nov 27. doi: 10.1002/ijc.35266. PubMedAbstract available
LU SSM, Rutegard M, Haggstrom C, Gylfe A, et al Prior antibiotics exposure is associated with an elevated risk of surgical site
infections, including anastomotic leakage, after colon cancer but not rectal
cancer surgery: A register-based study of 38,839 patients.
Int J Cancer. 2024 Nov 27. doi: 10.1002/ijc.35269. PubMedAbstract available
FENG X, Yao Q, Xu Y, Zhang J, et al Approaches for Lynch syndrome screening and characteristics of subtypes with
mismatch repair deficiency in patients with colorectal carcinoma.
Int J Cancer. 2024;155:1780-1791. PubMedAbstract available
REICHMANN R, Nimptsch K, Pischon T, Gunter MJ, et al Sex- and site-specific associations of circulating lipocalin 2 and incident
colorectal cancer: Results from the EPIC cohort.
Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35205. PubMedAbstract available
TRAILIN A, Ali E, Ye W, Pavlov S, et al Prognostic assessment of T-cells in primary colorectal cancer and paired
synchronous or metachronous liver metastasis.
Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35252. PubMedAbstract available
SCHEI-ANDERSEN AJ, Hendricks LAJ, van der Post RS, Mensenkamp AR, et al Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for
improved recognition: A single-center study.
Int J Cancer. 2024;155:1567-1576. PubMedAbstract available
October 2024
SONG CH, Kim N, Nam RH, Choi SI, et al Ninjurin1 deficiency differentially mitigates colorectal cancer induced by
azoxymethane and dextran sulfate sodium in male and female mice.
Int J Cancer. 2024 Oct 17. doi: 10.1002/ijc.35225. PubMedAbstract available
September 2024
DAMERELL V, Klaassen-Dekker N, Brezina S, Ose J, et al Circulating tryptophan-kynurenine pathway metabolites are associated with
all-cause mortality among patients with stage I-III colorectal cancer.
Int J Cancer. 2024 Sep 23. doi: 10.1002/ijc.35183. PubMedAbstract available
Correction to "Early weight loss is an independent risk factor for shorter
survival and increased side effects in patients with metastatic colorectal cancer
undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO
KRK-0306)".
Int J Cancer. 2024 Sep 18. doi: 10.1002/ijc.35186. PubMed
Expression of Concern: The retinoblastoma protein interacts with Bag-1 in human
colonic adenoma and carcinoma derived cell lines.
Int J Cancer. 2024;155:E9. PubMed
NG L, Sin RW, Cheung DH, Wong CK, et al Identification and evaluation of a serum microRNA panel to diagnose colorectal
cancer patients.
Int J Cancer. 2024 Sep 8. doi: 10.1002/ijc.35175. PubMedAbstract available
LONARE A, Raychaudhuri K, Shah S, Madhu G, et al 14-3-3sigma restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor
progression in colorectal cancer.
Int J Cancer. 2024 Sep 6. doi: 10.1002/ijc.35176. PubMedAbstract available
NESIC M, Rasmussen MH, Henriksen TV, Demuth C, et al Beyond basics: Key mutation selection features for successful tumor-informed
ctDNA detection.
Int J Cancer. 2024;155:925-933. PubMedAbstract available
August 2024
STERPETTI AV, Borrelli V, Sapienza P, Campagnol M, et al Comments on "Differences in survival and recurrence of colorectal cancer by stage
across population-based European registries".
Int J Cancer. 2024 Aug 27. doi: 10.1002/ijc.35150. PubMed
NAKATSUMI H, Komatsu Y, Harada K, Kawamoto Y, et al A multicenter, prospective, phase II trial of second-line aflibercept plus
FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR
antibody: HGCSG1801.
Int J Cancer. 2024 Aug 14. doi: 10.1002/ijc.35116. PubMedAbstract available
VAN DE WEERD S, Torang A, van den Berg I, Lammers V, et al Benefit of adjuvant chemotherapy on recurrence free survival per consensus
molecular subtype in stage III colon cancer.
Int J Cancer. 2024 Aug 8. doi: 10.1002/ijc.35120. PubMedAbstract available
July 2024
LI J, Roshelli Baker J, Aglago EK, Zhao Z, et al Pre-diagnostic plasma advanced glycation end-products and soluble receptor for
advanced glycation end-products and mortality in colorectal cancer patients.
Int J Cancer. 2024 Jul 26. doi: 10.1002/ijc.35114. PubMedAbstract available
LU L, Zhang Q, Aladelokun O, Berardi D, et al Asparagine synthetase and G-protein coupled estrogen receptor are critical
responders to nutrient supply in KRAS mutant colorectal cancer.
Int J Cancer. 2024 Jul 22. doi: 10.1002/ijc.35104. PubMedAbstract available
WEI TT, Blanc E, Peidli S, Bischoff P, et al High-confidence calling of normal epithelial cells allows identification of a
novel stem-like cell state in the colorectal cancer microenvironment.
Int J Cancer. 2024 Jul 19. doi: 10.1002/ijc.35079. PubMedAbstract available
DANKNER R, Chetrit A, Avraham SB, Agay N, et al A historical cohort study with 27,754 individuals on the association between meat
consumption and gastrointestinal tract and colorectal cancer incidence.
Int J Cancer. 2024 Jul 19. doi: 10.1002/ijc.35084. PubMedAbstract available
RAFIQUE A, Ali I, Kim S, Farooq A, et al Toll-like receptor 13-mediated signaling protects against the development of
colon cancer.
Int J Cancer. 2024 Jul 11. doi: 10.1002/ijc.35089. PubMedAbstract available
NISHIHARA K, Nakano S, Yamaji T, Goto A, et al Height, body mass index, physical activity, and risk of colorectal cancer in
relation to expression of insulin receptor: The Japan Public Health Center-based
Prospective Study.
Int J Cancer. 2024 Jul 6. doi: 10.1002/ijc.35075. PubMedAbstract available
HAMMARSTROM K, Nunes L, Mathot L, Mezheyeuski A, et al Clinical and genetic factors associated with tumor response to neoadjuvant
(chemo)radiotherapy, survival and recurrence risk in rectal cancer.
Int J Cancer. 2024;155:40-53. PubMedAbstract available
May 2024
HOLTHUIJSEN DDB, van Roekel EH, Bours MJL, Ueland PM, et al Longitudinal associations of plasma kynurenines and ratios with fatigue and
quality of life in colorectal cancer survivors up to 12 months post-treatment.
Int J Cancer. 2024 May 23. doi: 10.1002/ijc.34992. PubMedAbstract available
WANG R, Lv C, Li D, Song Y, et al EEF1D stabilized by SRSF9 promotes colorectal cancer via enhancing the
proliferation and metastasis.
Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35039. PubMedAbstract available
HU M, Luo R, Yang K, Yu Y, et al Genomic landscape defines peritoneal metastatic pattern and related target of
peritoneal metastasis in colorectal cancer.
Int J Cancer. 2024 May 13. doi: 10.1002/ijc.35005. PubMedAbstract available
WANG P, Song M, Eliassen AH, Wang M, et al Identifying modifiable risk factors to prevent aggressive colorectal cancer.
Int J Cancer. 2024 May 8. doi: 10.1002/ijc.34993. PubMedAbstract available
VAN LANEN AS, Kok DE, Wesselink E, Derksen JWG, et al Associations between low- and high-fat dairy intake and recurrence risk in people
with stage I-III colorectal cancer differ by sex and primary tumour location.
Int J Cancer. 2024 May 3. doi: 10.1002/ijc.34959. PubMedAbstract available
HO VKY, Deijen CL, Hemmes B, van Erning FN, et al Trends in epidemiology and primary treatment of anal squamous cell carcinoma in
the Netherlands (1990-2021).
Int J Cancer. 2024;154:1569-1578. PubMedAbstract available
BECERRA-TOMAS N, Markozannes G, Cariolou M, Balducci K, et al Post-diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update
Programme (CUP Global) systematic literature review and meta-analysis.
Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34905. PubMedAbstract available
MARKOZANNES G, Becerra-Tomas N, Cariolou M, Balducci K, et al Post-diagnosis physical activity and sedentary behaviour and colorectal cancer
prognosis: A Global Cancer Update Programme (CUP Global) systematic literature
review and meta-analysis.
Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34903. PubMedAbstract available
CHAN DSM, Cariolou M, Markozannes G, Balducci K, et al Post-diagnosis dietary factors, supplement use and colorectal cancer prognosis: A
Global Cancer Update Programme (CUP Global) systematic literature review and
meta-analysis.
Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34906. PubMedAbstract available
TSILIDIS KK, Markozannes G, Becerra-Tomas N, Cariolou M, et al Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary
factors, supplement use and colorectal cancer prognosis: Global Cancer Update
Programme (CUP Global) summary of evidence grading.
Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34904. PubMedAbstract available
April 2024
VASAVADA A, Stankiewicz Karita HC, Lin J, Schouten J, et al Methylation markers for anal cancer screening: A repeated cross-sectional
analysis of people living with HIV, 2015-2016.
Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34977. PubMedAbstract available
ZHANG Y, Win AK, Makalic E, Buchanan DD, et al Associations between pathological features and risk of metachronous colorectal
cancer.
Int J Cancer. 2024 Apr 27. doi: 10.1002/ijc.34979. PubMedAbstract available
FU X, Huang J, Zhu J, Fan X, et al Prognosis and immunotherapy efficacy in dMMR&MSS colorectal cancer patients and
an MSI status predicting model.
Int J Cancer. 2024 Apr 9. doi: 10.1002/ijc.34946. PubMedAbstract available
BOUVIER AM, Jooste V, Lillini R, Marcos-Gragera R, et al Differences in survival and recurrence of colorectal cancer by stage across
population-based European registries.
Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34944. PubMedAbstract available
SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al Antibodies against high-risk human papillomavirus proteins as markers for
noncervical HPV-related cancers in a Black South African population, according to
HIV status.
Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919. PubMedAbstract available
MOEN L, Liu B, Bukirwa P, Chingonzoh T, et al Trends in the incidence of colorectal cancer in sub-Saharan Africa: A
population-based registry study.
Int J Cancer. 2024 Apr 3. doi: 10.1002/ijc.34942. PubMedAbstract available
BRENNER H, Weber L, Cardoso R, Heisser T, et al Indications of sustained delay of colorectal cancer diagnoses in Germany during
the first 2 years of the COVID-19 pandemic.
Int J Cancer. 2024 Apr 1. doi: 10.1002/ijc.34943. PubMed
March 2024
LI YJ, Wang X, Wu YJ, Zhou XY, et al Access to colorectal cancer screening in populations in China, 2020: A
coverage-focused synthesis analysis.
Int J Cancer. 2024 Mar 30. doi: 10.1002/ijc.34938. PubMedAbstract available
DOHERTY N, Cardwell C, Murchie P, Hill C, et al Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men
with benign prostatic hyperplasia: A population-based cohort study.
Int J Cancer. 2024 Mar 30. doi: 10.1002/ijc.34937. PubMedAbstract available
TAN JY, Yeo YH, Ng WL, Fong ZV, et al How have US colorectal cancer mortality trends changed in the past 20 years?
Int J Cancer. 2024 Mar 25. doi: 10.1002/ijc.34926. PubMedAbstract available
DAL MASO L, Toffolutti F, De Paoli A, Giudici F, et al Cure indicators and prevalence by stage at diagnosis for breast and colorectal
cancer patients: A population-based study in Italy.
Int J Cancer. 2024 Mar 23. doi: 10.1002/ijc.34923. PubMedAbstract available
ZNAOR A, Eser S, Bendahhou K, Shelpai W, et al Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A
population-based cancer registry study.
Int J Cancer. 2024 Mar 8. doi: 10.1002/ijc.34895. PubMedAbstract available
HORESH N, Emile SH, Garoufalia Z, Gefen R, et al Trends in management and outcomes of colon cancer in the United States over
15 years: Analysis of the National Cancer Database.
Int J Cancer. 2024 Mar 7. doi: 10.1002/ijc.34910. PubMedAbstract available
JEZIORSKI K Improving colon cancer screening in Poland. In search of the Holy Grail.
Int J Cancer. 2024 Mar 4. doi: 10.1002/ijc.34909. PubMed
February 2024
LINDQUIST S, Frederiksen K, Petersen LK, Kjaer SK, et al The risk of vaginal, vulvar and anal precancer and cancer according to high-risk
HPV status in cervical cytology samples.
Int J Cancer. 2024 Feb 28. doi: 10.1002/ijc.34896. PubMedAbstract available
January 2024
STIER EA, Clarke MA, Deshmukh AA, Wentzensen N, et al International Anal Neoplasia Society's consensus guidelines for anal cancer
screening.
Int J Cancer. 2024 Jan 31. doi: 10.1002/ijc.34850. PubMedAbstract available